Cardiovascular Animation – Autonomic Regulation Therapy
The LivaNova VITARIA System is currently being evaluated in patients with continued heart failure after therapy. It is designed to deliver Autonomic Regulation Therapy (ART) through electrical stimulation of the vagus nerve.
This animation highlights how ART can restore balance within the cardiac nervous system to treat chronic heart failure. It has been developed in three sections; the first introducing the cardiovascular system and its control by the autonomic nervous system (ANS), the second showing the development of cardiac disease and its effects on ANS function, and the final showing how the VITARIA System utilizes ART to restore ANS function and stop the progression of cardiovascular disease and the resulting heart failure.
The three-step-approach allows the science behind the LivaNova VITARIA System to come across in a way that is clear and easily understood.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.’’
Product Manager, GSK
‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.’’
Oncology Clinical Liaison, Bristol-Myers Squibb
‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen